Skip to Content
🌐Ship toSelect country

Stylage Bi-Soft Lips Plus Lidocaine - 1 x 1,0ml

Stylage Bi-Soft Lips Plus is a Laboratoires Vivacy lip filler with a higher 20mg/g cross-linked hyaluronic acid concentration than Special Lips, plus mannitol and 0.3% lidocaine. It is designed to enlarge and define the lips, redefine lip contours, treat perioral wrinkles and correct upper/lower lip proportion, with the antioxidant mannitol slowing HA breakdown for longer-lasting results. For use by licensed, trained medical professionals only.

72.00 € 72.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand STYLAGE®
SKU A5225 Share
Treatment Areas Lips
Tags ContouringCross-Linked Hyaluronic AcidHydrationLidocaineVolumizer

Stylage Bi-Soft Lips Plus Lidocaine is Laboratoires Vivacy's lip-enhancement formulation, built on IPN-Like cross-linking technology with mannitol as an antioxidant, pre-mixed with lidocaine for a more comfortable injection experience, designed to enhance lip volume and definition.

CONCENTRATION

  • Cross-linked hyaluronic acid (IPN-Like technology) + mannitol
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 6-9 months, depending on individual metabolism.

INDICATIONS

  • Lip volume loss
  • Lip contour and definition

TREATMENT AREAS

  • Lips
  • Mouth

Stylage Bi-Soft Lips Plus Lidocaine is injected into the lip tissue using linear threading or micro-bolus technique.

Results are visible immediately, with final results assessed after 1-2 weeks once any swelling has resolved.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin
  • Active infection or cold sores in the treatment area